Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation

With the development of nanotechnology, significant progress has been made in the design, and manufacture of nanoparticles (NPs) for use in clinical treatments. Recent increases in our understanding of the central role of macrophages in the context of inflammation and cancer have reinvigorated inter...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Hu, Guorong, Guo, Mengfei, Xu, Juanjuan, Wu, Feng, Fan, Jinshuo, Huang, Qi, Yang, Guanghai, Lv, Zhilei, Wang, Xuan, Jin, Yang
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6712945/
https://ncbi.nlm.nih.gov/pubmed/31497026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01998
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars